Evidence map›Paper›PMID 42505515›Full record

ReviewBiomimetics (Basel, Switzerland)2026

Macrophage Membrane-Coated Nanoparticles for Immunomodulation and Bone Regeneration: Emerging Applications in Oral and Dental Implant Therapy.

Sara Derhambakhsh, Tulio Fernandez-Medina, Elsa Antunes, Suchandan Sikder, Ernest Jennings, Catherine M Miller

Abstract readReview
In one paragraph

Review in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sara DerhambakhshCollege of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia.
Tulio Fernandez-MedinaCollege of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia.ORCID 0000-0002-5659-7884
Elsa AntunesCollege of Science and Engineering, James Cook University, Townsville, QLD 4811, Australia.
Suchandan SikderAustralian Institute of Tropical Health and Medicine, James Cook University, Cairns, QLD 4878, Australia.
Ernest JenningsCollege of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia.ORCID 0000-0002-8912-6894
Catherine M MillerCollege of Medicine and Dentistry, James Cook University, Cairns, QLD 4878, Australia.ORCID 0000-0001-6071-5102

Funding

James Cook University
6 · The paper itself

Abstract

Macrophage membrane-coated nanoparticles (MMNPs) are an emerging class of biomimetic nanoplatforms that combine the immune-regulatory functions of macrophages with the structural versatility of synthetic nanoparticles (NPs). By retaining key membrane proteins and receptors, MMNPs exhibit natural targeting capabilities, immune interactions, and inflammatory site homing, making them promising tools for immunomodulation and targeted therapy. This review summarizes macrophage biology relevant to immune regulation and discusses how nanoparticle core properties, including size, surface charge, composition, and mechanical characteristics, influence membrane coating efficiency, stability, and biological performance. Current fabrication and characterization strategies for MMNPs are also discussed. Particular emphasis is placed on the therapeutic applications of MMNPs in inflammatory disorders, tissue regeneration, and oral and dental implant-related applications. Recent studies demonstrate that MMNPs can modulate macrophage polarization, sequester pro-inflammatory cytokines, remodel the immune microenvironment, and promote tissue repair and bone regeneration, highlighting their potential to improve implant integration and reduce inflammation-associated implant failure. Despite these promising advances, challenges remain regarding large-scale manufacturing, membrane preservation, reproducibility, and long-term biosafety. Continued interdisciplinary research in nanotechnology, immunology, and biomaterials engineering is expected to accelerate the clinical translation of MMNPs for regenerative and immunomodulatory therapies.

Indexed as

biomimetic nanocarriersdental implantsimmune modulationinflammationmacrophage membrane-coated nanoparticlesoral diseasestissue regeneration

Identifiers

PMID42505515
PMCPMC13407334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.